We are live on
!
Find out more
CCM
Crossvault Capital Management Portfolio holdings
AUM
$254M
1-Year Est. Return
5.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.17%
1 Year Est. Return
-5.07%
3 Year Est. Return
+56.38%
5 Year Est. Return
+114.39%
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$101M
Cap. Flow
% of AUM
97.14%
Top 10 Holdings %
Top 10 Hldgs %
37.79%
Holding
59
New
59
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$5.33M |
| 2 |
Starbucks
SBUX
|
+$4.11M |
| 3 |
GE Aerospace
GE
|
+$4.06M |
| 4 |
Apple
AAPL
|
+$3.66M |
| 5 |
Pfizer
PFE
|
+$3.43M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.3% |
| 2 | Energy | 14.88% |
| 3 | Consumer Discretionary | 14.01% |
| 4 | Industrials | 10.83% |
| 5 | Technology | 8.37% |
Similar funds
HA
PPW
SG
ETI
RIM
TF
TWM
IC
Crossvault Capital Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Crossvault Capital Management, which disclosed 59 positions worth $104M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Bristol-Myers Squibb: 104,588 shares worth $5.56M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, followed by Energy and Consumer Discretionary.
- Crossvault Capital Management's largest Q4 2013 buy was Bristol-Myers Squibb: 104,588 shares worth $5.56M.
- Crossvault Capital Management's ten largest holdings make up 38% of its $104M portfolio in Q4 2013.
- Crossvault Capital Management disclosed 59 positions in Q4 2013, its first 13F filing on record.
Based on Crossvault Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.